Neuroscientist Kenneth Kosik to receive 2021 Potamkin Prize for his Alzheimer’s research
Alzheimer's disease
-
-
A woman who defied a genetic mutation that guarantees early-onset Alzheimer’s donates her brain to research -
A woman’s resistance to genetic, early-onset Alzheimer’s may hold the key to future therapies for the neurodegenerative disease -
A ‘druggable’ mechanism of tau protein pathology could lead to new treatment for dementia -
Another early-onset Alzheimer’s gene mutation is found in a Colombian family, and is traced back to Africa -
New insight into the mechanism of tau protein aggregation could lead to better in vitro models for neurodegenerative disease research
-
Alzheimer’s researchers begin to unravel how the protein tau transitions from soluble liquid to solid fibrous tangle -
UCSB neuroscientist Kenneth Kosik examines the importance of basic cell biology research -
The documentary “Can Alzheimer’s be Stopped?” screens at UCSB’s Pollock Theater, followed by a panel discussion -
A new book by UCSB neuroscientist Kenneth S. Kosik offers strategies for reducing the risk of Alzheimer’s disease -
Multiple drug development efforts for treating Alzheimer’s would operate simultaneously
